PQE Group Launches AI and Data Analytics Division: Innovation in the Service of Life Science
June 25 2024 - 11:20AM
Business Wire
The Italian Consultancy Group, with over 45
global branches, invests in artificial intelligence: establishing a
new department and a strategic partnership for a cutting-edge and
responsible future
PQE Group, a leading consultancy in the Life Science sector,
announces the consolidation of its new Regulated Artificial
Intelligence & Data Analytics division operating since the
initiation of AI based tools in the industrial space. This marks a
pivotal step in the company's evolution, positioning the Italian
Group, comprised of more than 2000 employees, at the forefront of
technological innovation in Life Sciences. The new division is
designed to enhance business process efficiency and effectiveness
while ensuring regulatory compliance. Leveraging advanced
technologies, PQE Group offers services like AI-driven decision
optimization, risk reduction, and accelerated innovation, all
adhering to industry regulations. The 2024 Stanford Report on AI
highlighted AI's significant role in accelerating scientific
discovery in 2022, with further strengthening in 2023.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240625598895/en/
Danilo Neri - Partner & Vice
President Executive at PQE Group (Photo: PQE Group)
“Regulators have started addressing the expectations for these
solutions, but there is still much to do, since regulated companies
need detailed guidance on documentation required to ensure
explainability and performance of each tool," emphasized Danilo
Neri, Partner & Vice President Executive of PQE Group. "Just a
few weeks ago, the final approval of the AI Act in the European
Union was granted, representing the world's most advanced
regulation on artificial intelligence, requiring documentation to
address explainability. It is an important step, but it is equally
important that penalties are effectively applied to offenders to
not compromise consumer, worker, and citizen protection at the
expense of innovation and market competitiveness. The full
establishment of this division will allow us to consolidate our
position as a leader in the sector, offering exceptional compliance
approaches and tailor-made solutions to our clients that meet
regulatory expectations and the increasingly complex market needs."
PQE Group’s dedicated validation approach has been designed to meet
the current regulatory expectations for machine learning-based
tools and for Generative AI solutions.
PQE Group's partnership with the Canadian company GenAIz will
further boost service capacity. GenAIz, focused on the use of AI
for supporting humanity, has developed a platform to speed up
decision-making and execution with better business insights. This
collaboration will enhance PQE Group's ability to offer innovative
solutions and the necessary validation packages required by GxP
regulations and by incoming industry wide rules (e.g., European AI
act). Led by Catherine Lunardi, CEO of GenAIz and a spokesperson at
the G7 on AI and wellbeing, GenAIz's AI platform will leverage PQE
Group's global presence, which includes more than 45 offices
worldwide.
The Regulated Artificial Intelligence & Data Analytics
division will be presented in a panel discussion and networking
event in Rockville, MD, on July 17, 2024. Experts will discuss AI
regulations and the future of life sciences, marking a significant
innovation for the pharmaceutical and medical device industry.
The press and readers are warmly invited
to the event.
Please confirm attendance and find more information by
registering here: https://hubs.ly/Q02CMQrj0
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240625598895/en/
PQE Group Press Office
Michela Lijoi
press@pqegroup.com m.lijoi@pqegroup.com
Tel: +39 328 6353044